Literature DB >> 33096030

The apoM-S1P axis in hepatic diseases.

Zhiyang Chen1, Min Hu2.   

Abstract

Liver dysfunction is always accompanied by lipid metabolism dysfunction. Apolipoprotein M (apoM), a member of the apolipoprotein family, is primarily expressed and secreted from the liver. apoM is the main chaperone of sphingosine-1-phosphate (S1P), a small signalling molecule associated with numerous physiologic and pathophysiologic processes. In addition to transport, apoM also influences the biologic effects of S1P. Most recently, numerous studies have investigated the potential role of the apoM-S1P axis in a variety of hepatic diseases. These include liver fibrosis, viral hepatitis B and C infection, hepatobiliary disease, non-alcoholic and alcoholic steatohepatitis, acute liver injury and hepatocellular carcinoma. In this review, the roles of apoM and S1P in the development of hepatic diseases are summarized, and novel insights into the diagnosis and treatment of hepatic diseases are discussed.
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hepatic diseases; Sphingosine-1-phosphate; apolipoprotein M

Mesh:

Substances:

Year:  2020        PMID: 33096030     DOI: 10.1016/j.cca.2020.10.023

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  5 in total

Review 1.  The HDL Proteome Watch: Compilation of studies leads to new insights on HDL function.

Authors:  W Sean Davidson; Amy S Shah; Hannah Sexmith; Scott M Gordon
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2021-11-18       Impact factor: 4.698

2.  Serum sphingosine-1 phosphate level is increased in patients with hepatitis B and displays a positive association with liver fibrosis.

Authors:  Mei Sun; Ling Zeng; Min Hu
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

Review 3.  The Difference Between High Density Lipoprotein Subfractions and Subspecies: an Evolving Model in Cardiovascular Disease and Diabetes.

Authors:  W Sean Davidson; Allison L Cooke; Debi K Swertfeger; Amy S Shah
Journal:  Curr Atheroscler Rep       Date:  2021-03-27       Impact factor: 5.113

4.  Non-alcoholic fatty liver disease-associated DNA methylation and gene expression alterations in the livers of Collaborative Cross mice fed an obesogenic high-fat and high-sucrose diet.

Authors:  Volodymyr P Tryndyak; Rose A Willett; Mark I Avigan; Arun J Sanyal; Frederick A Beland; Ivan Rusyn; Igor P Pogribny
Journal:  Epigenetics       Date:  2022-03-24       Impact factor: 4.861

Review 5.  Targeting Chronic Inflammation of the Digestive System in Cancer Prevention: Modulators of the Bioactive Sphingolipid Sphingosine-1-Phosphate Pathway.

Authors:  Eileen M McGowan; Yiguang Lin; Size Chen
Journal:  Cancers (Basel)       Date:  2022-01-21       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.